A Polymorphism in MAPKAPK3 Affects Response to Interferon Therapy for Chronic Hepatitis CHironobu Tsukada, Kazuaki Chayama, Yoshifumi Fujimoto et al.|Gastroenterology|2009Cited by 42
A single nucleotide polymorphism in activated cdc42 associated tyrosine kinase 1 influences the interferon therapy in hepatitis C patientsYoshifumi Fujimoto, Kazuaki Chayama, Hidenori Ochi et al.|Journal of Hepatology|2010Cited by 20